Status:

UNKNOWN

Efficiency of an mHealth Intervention on the Health Literacy Improvement and Self-management.

Lead Sponsor:

Instituto de investigación e innovación biomédica de Cádiz

Conditions:

Heart Failure

Multi-pathology

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Multipathological patients with complex health needs are responsible for the majority number of avoidable hospital admissions. The expansion of mHealth interventions in the field of communication wit...

Detailed Description

Objective: to evaluate the efficacy of an mHealth intervention, with respect to routine clinical practice, to improve health literacy and self-management of the multiple pathological patient with hear...

Eligibility Criteria

Inclusion

  • Patients of both sexes and over 18 years of age;
  • Attended by the health professionals of the Basic Health Areas that are participating in the study;
  • Patients that give their consent to participate in the study by signing an informed consent;
  • Patients that have a mobile device (Smartphone or Tablet) compatible with the Android or iOS operating system;
  • Patients considered as multi-pathological based on the following criteria from those described in the Integrated Healthcare Process (Ollero et al., 2018):
  • Be classified in clinical category A of chronic pathologies due to heart failure that, in a situation of clinical stability, has been in NYHA grade II, being able to be simultaneously classified, or not, in other clinical categories due to suffering from another disease Chronicles.
  • Patients with at least one of the following complexity criteria: Extreme polypharmacy (10 or more active ingredients for chronic prescription); Socio-family risk (score on the Gijon scale greater than 10 points); Stage II or higher pressure ulcers; Malnutrition (BMI \<18.5); Feeding with chronic and prescription tube (3 or more months); Two or more hospital admissions in the previous 12 months.

Exclusion

  • Patients with sensory deficits and/or mobility problems in the upper limbs that prevent them from using the application correctly, despite using the accessibility features of mobile devices;
  • Patients with persistent cognitive impairment (Pfeiffer test with 5 or more errors or Lobo's mini-cognitive exam \<23 points) and / or severe mental disorder;
  • Patients with serious limitations for AVBD (Barthel index \<20 points).

Key Trial Info

Start Date :

March 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2024

Estimated Enrollment :

236 Patients enrolled

Trial Details

Trial ID

NCT04725526

Start Date

March 1 2020

End Date

January 1 2024

Last Update

August 8 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Health Management area of Gibraltar

Algeciras, Cádiz, Spain, 11207

2

F. para la Gestión de la Inv. Biomédica de Cádiz Ríos

Cadiz, Spain, 11009